Author:
Stevens Lesley A.,Greene Tom,Levey Andrew S.
Publisher
American Society of Nephrology (ASN)
Subject
Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology
Reference52 articles.
1. Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials
2. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
3. Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
4. Chakravarty AG: Surrogate Markers: Their Role in Regulatory Decision Process, Washington, DC, FDA, 2003. Available: http://www.fda.gov/cder/Offices/Biostatistics/Chakravarty_376/index.htm. Accessed February 12, 2006
5. Wesson L: Physiology of the Human Kidney, New York, Grune & Stratton, 1969
Cited by
117 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献